| |
 |
|
Home > In Vitro Diagnostics > Clinical Chemistry > US Self-monitoring Blood Glucose Market
|
US Self-monitoring Blood Glucose Market
|
 |
|
 |
This market insight focuses on the developments in the self-monitoring blood glucose market in the United States. Reimbursement analysis and the effects of competitive bidding have been studied. Thorough product analyses for more than 73 SMBG meters have been performed, based on the various features of differentiation. The market insight discusses metrics for meters and strips, and does not include insulin pumps and lancets. Unit and revenue analysis for the years 2012–2016 have been projected in this report.
Executive Summary
- The US SMBG market was valued at $ billion in 2013 and is expected to increase to $ billion by 2016. About % of the revenue is contributed by the SMBG strip market, and % of the demand arises from the sale of meters.
- The market is currently dominated by Roche Diagnostics (brand Accu Chek), LifeScan (J&J) (brand OneTouch), and Bayer Healthcare (CONTOUR).
- Online sales of meters and strips is increasing. Popular eCommerce vendors (e.g., Amazon) are the leaders in online supplies. Developing eCommerce channels could be an important step for any Tier I vendor fighting against mature market competitors.
- Smart phone connectivity and exploring non-invasive methods are some key areas that manufacturers are focussing on, to offer product differentiation from the competition. Thus, blood glucose meters are now increasingly becoming a part of the mhealth market.
- Within the United States, the mail order supply program has created a downside effect for small, independent retail clinics. This is also expected to make the diabetic scenario more adverse in the United States, thereby increasing the prevalence of the disease in the coming years, owing to the deficit in supply channels.
- The generic test strip market is creating stiff competition for Tier I manufacturers, forcing price pressures, thereby, shrinking the market. Currently, UniStrip Technologies has taken the forefront in the generic market. A 50-count box of its strips costs about $. These strips will be seen flooding the shelves of retail stores for as low as $.
Key Questions This Study Will Attempt to Answer
- Is the market growing? How long will it continue to grow, and at what rate?
- What is the current state of the competitive landscape?
- What are the current industry and technology trends?
- What’s the next big thing in the diabetes SMBG market landscape? Who are the new participants?
- What are the opportunities that a participant can capitalize on?
- How is the distribution landscape currently spread out in the United States?
- What are the effects of Medicare reimbursement and the national mail order program?
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $5000.00
Other Formats: Global PDF, DataPack
|
 |
| |
|
 |
| |
|
|
|